Clinical trial
Prevalence of Genetic Polymorphisms in Genes Coding for Tamoxifen Metabolising Enzymes, in Postmenopausal ER-positive Breast Cancer Patients According to Uterine and Biochemical Changes and Tolerability of Tamoxifen.
NCT00966043 is registered in ClinicalTrials.gov with Vlaamse Vereniging voor Obstetrie en Gynaecologie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Genetic Polymorphisms in Genes Coding for Tamoxifen Metabolising Enzymes, in Postmenopausal ER-positive Breast Cancer Patients According to Uterine and Biochemical Changes and Tolerability of Tamoxifen.
- Lead sponsor
- Vlaamse Vereniging voor Obstetrie en Gynaecologie
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2009
- Completion date
- July 31, 2011
- Enrollment
- 158 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.